Leadership
Xencor Announces the Planned Retirement of Chief Medical Officer Paul Foster, M.D.
Xencor, Inc.
PR-M07-19-NI-006-2425Jul 03, 2019
License Agreement
Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates
Selexis SA
PR-M03-18-NI-009Mar 02, 2018